Author:
Lin Shao,Herdt-Losavio Michele,Gensburg Lenore,Marshall Elizabeth,Druschel Charlotte
Subject
Developmental Biology,Embryology,General Medicine,Pediatrics, Perinatology, and Child Health
Reference21 articles.
1. Agency for Toxic Substances and Disease Registry. 2004. Maternal exposure to volatile organic compounds and the risk of congenital heart defects. Springfield, Virginia: National Technical Information Service; Publication number PB2004-102339.
2. Teratogenicity by the hERG potassium channel blocking drug almokalant: use of hypoxia marker gives evidence for a hypoxia-related mechanism mediated via embryonic arrhythmia;Danielsson;Toxicol Appl Pharmacol,2003
3. Product Information: Ventolin (albuterol, USP) Inhalation Aerosol;GlaxoSmithKline;GlaxoSmithKline RL-963,2001
4. Risk of congenital malformations associated with treatment of asthma during early pregnancy;Jadad;Lancet,2000
5. Use of anti-asthmatic drugs during pregnancy.3. Congenital malformations in the infants;Kallen;Eur J Clin Pharmacol,2007
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献